Published in Can J Physiol Pharmacol on January 01, 1998
Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. Br J Pharmacol (2007) 0.88
Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol (2012) 0.88
Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens (2013) 0.84
Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice. Am J Physiol Heart Circ Physiol (2014) 0.78
Characterization of optimal resting tension in human pulmonary arteries. World J Cardiol (2016) 0.75
Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol (1988) 4.16
Determination of glycogen in small tissue samples. J Appl Physiol (1970) 2.93
Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17
Laparoscopic cholecystectomy. A statewide experience. The Connecticut Laparoscopic Cholecystectomy Registry. Arch Surg (1993) 2.16
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01
Surgery by non-surgeons: podiatric surgery in Connecticut. Conn Med (1989) 2.01
Occupational injury deaths in Alaska's fishing industry, 1980 through 1988. Am J Public Health (1993) 1.94
Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol (2007) 1.88
Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res (1999) 1.78
The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med (2000) 1.68
Release of gelatinase A during platelet activation mediates aggregation. Nature (1997) 1.65
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg (2001) 1.55
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Agricultural machine-related deaths. Am J Public Health (1991) 1.50
Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction. Reprod Sci (2013) 1.45
Activation of Ca(2+)-independent nitric oxide synthase by 17beta-estradiol in post-ischemic rat heart. Cardiovasc Res (2000) 1.44
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost (1999) 1.43
Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol (1999) 1.41
Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension (1999) 1.41
Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med (1993) 1.40
Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer (1994) 1.39
Operative management of radiation injuries of the intestinal tract. Am J Surg (1979) 1.29
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A (1994) 1.29
Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res (1994) 1.28
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet (1994) 1.20
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res (2000) 1.19
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res (2001) 1.18
Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun (1993) 1.15
Comparison of mortality rates for open and closed cholecystectomy in the elderly: Connecticut statewide survey. J Laparoendosc Surg (1994) 1.15
The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol (1995) 1.14
Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res (2001) 1.14
Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am J Physiol Heart Circ Physiol (2005) 1.14
Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]. FASEB J (2001) 1.12
The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol (1998) 1.12
Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis (2006) 1.09
Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost (1998) 1.07
Outcome study of cholecystectomy during pregnancy. Am J Surg (1999) 1.07
Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy (2001) 1.03
Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem (1999) 1.01
Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am J Physiol Regul Integr Comp Physiol (2010) 1.01
Sleep deprivation and the effect on exercise performance. Sports Med (1989) 1.00
Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. Can J Physiol Pharmacol (1999) 0.99
Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis. Clin Immunol Immunopathol (1997) 0.98
Effect of estrogen replacement on vasoconstrictor responses in rat mesenteric arteries. Hypertension (1999) 0.95
Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod (2000) 0.95
Medical examiner/coroner records: uses and limitations in occupational injury epidemiologic research. J Forensic Sci (1990) 0.94
Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol (1997) 0.94
Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand (2003) 0.93
Response of lipoprotein lipase in various tissues to cold exposure. Am J Physiol (1971) 0.93
Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension (2000) 0.93
Clinical studies on men continuously exposed to airborne particulate lead. Environ Qual Saf Suppl (1975) 0.93
Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. J Appl Physiol (1985) (2011) 0.92
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. Br J Pharmacol (2011) 0.92
Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome. Biochem Soc Trans (2007) 0.92
Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension (1995) 0.92
Effect of oxygen levels in villous trophoblast apoptosis. Placenta (2003) 0.92
Contribution of exertional hyperthermia to sympathoadrenal-mediated lymphocyte subset redistribution. J Appl Physiol (1985) (1999) 0.91
Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin. Br J Pharmacol (2001) 0.91
The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther (1998) 0.91
Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol (1994) 0.91
Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br J Pharmacol (2001) 0.90
Regulation of intracellular Ca2+ in the heart during diabetes. Cardiovasc Res (1997) 0.90
Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction. Int J Obes Relat Metab Disord (1992) 0.90
Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance. Br J Pharmacol (2012) 0.89
In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without pre-eclampsia. Placenta (2007) 0.89
Removal and recovery of halothane and methoxyflurane from waste anaesthetic vapours. Can Anaesth Soc J (1967) 0.89
Colonic complications of acute pancreatitis and pancreatic abscess. Am J Surg (1983) 0.89
Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response. Int J Sports Med (1995) 0.89
Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis (1998) 0.88
Holy dogs and the laboratory: some Canadian experiences with animal research. Perspect Biol Med (1985) 0.88
Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat. J Appl Physiol (1985) (1991) 0.88
Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet (1998) 0.88
Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta (2012) 0.88
Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg (2001) 0.87
Mycotic emboli of the peripheral vessels: analysis of forty-four cases. Surgery (1981) 0.87
Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther (1992) 0.87
Vascular function in alcohol-treated pregnant and nonpregnant mice. Am J Physiol Regul Integr Comp Physiol (2001) 0.87
Reassessing the mathematical modeling of the contribution of vasomotion to vascular resistance. J Appl Physiol (1985) (2002) 0.87
Development of "sports anemia" in physically fit men after daily sustained submaximal exercise. Aviat Space Environ Med (1980) 0.87
Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther (1994) 0.86
Breath ethyl alcohol concentration and analysis in the presence of chronic obstructive pulmonary disease. Clin Biochem (1983) 0.86
Bacteriophage typing as an epidemiological tool for urinary Escherichia coli. Appl Microbiol (1969) 0.86
Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Atherosclerosis (1988) 0.86
Endurance exercise with and without a thermal clamp: effects on leukocytes and leukocyte subsets. J Appl Physiol (1985) (1996) 0.86
Intense exercise and food restriction cause similar hypothalamic neuropeptide Y increases in rats. Am J Physiol (1993) 0.86
Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. J Lipid Res (1992) 0.86
Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress. Am J Obstet Gynecol (1996) 0.86
Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med Sci Monit (2001) 0.86
Cytokine induction during exertional hyperthermia is abolished by core temperature clamping: neuroendocrine regulatory mechanisms. Int J Hyperthermia (2004) 0.85
Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest (1995) 0.85
A technique for long-term venous cannulation in rats. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.85
Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension (2000) 0.85
Maternal smoking and preeclampsia. J Reprod Med (2000) 0.85
Modulation of vasomotion in resistance arteries of JCR:LA-cp rats: a model of insulin resistance. Can J Physiol Pharmacol (1999) 0.85
Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood. Diabetologia (1998) 0.85